AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2017
Dec 4, 2017
30016_dirs_2017-12-04_8850e0ab-81e6-4473-b997-4ad84ae3d5aa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2017-11-30
Reporting Person: TWIGGE GIOVANI (Chief Human Resources Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-11-30 | Common Stock | S | 1442 | $156.0929 | Disposed | 14960 | Direct |
| 2017-11-30 | Common Stock | S | 558 | $156.0060 | Disposed | 14402 | Direct |
Footnotes
F1: Represents the weighted average sales price of the shares sold ranging from a low of $156.05 to a high of $156.155 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F2: Includes a total of 70 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on June 30, 2017 and September 29, 2017.
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 26
Regulatory Filings
2026
Mar 13